To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene ATICTABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
398 supporting clones for gene ATIC back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
AK298142   .a 1 to 2186 2 to 2187 T123S S174F tiling clone,   2187/2187
(100 %)
4 diff
(99.9 %id)
DC360014   .a 1 to 470 2 to 471       471/471
(100 %)
2 diff
(99.6 %id)
BE257785 eye, retinoblastoma .a 47 to 700 1 to 711       514/711
(72 %)
23 diff
(96.8 %id)
TI_44168989   .a 52 to 689 80 to 717       638/718
(88 %)
8 diff
(98.9 %id)
BI547631 brain, hippocampus .a 53 to 689 1 to 637   tiling clone,   637/638
(99 %)
5 diff
(99.3 %id)
BU151196 eye, normal pigmented retinal epithelium .a 59 to 824 1 to 769   tiling clone,   769/936
(82 %)
14 diff
(98.6 %id)
DB470619 hippocampus .a 64 to 229 1 to 166       166/166
(100 %)
11 diff
(93.4 %id)
DC319062 brain .a 256 to 846 1 to 591   tiling clone,   591/591
(100 %)
1 diff
(99.9 %id)
BM468208 leiomyosarcoma, uterus .b 1 to 978 45 to 1030   tiling clone, AAA   993/1071
(92 %)
26 diff
(97.6 %id)
DA487775 brain .b 1 to 549 6 to 554   capped   553/553
(100 %)
0 diff
(100 %id)
DA903071   .b 1 to 554 6 to 559   capped   558/558
(100 %)
0 diff
(100 %id)
DA377526 thalamus .b 1 to 569 2 to 570   capped   569/569
(100 %)
0 diff
(100 %id)
DA748473   .b 1 to 522 2 to 523   capped   522/522
(100 %)
0 diff
(100 %id)
DA679856   .b 42 to 505 2 to 465   capped   464/464
(100 %)
0 diff
(100 %id)
DA908598   .b 59 to 625 2 to 568   capped   567/567
(100 %)
0 diff
(100 %id)
DA000213   .b 61 to 570 2 to 511   capped   510/510
(100 %)
0 diff
(100 %id)
DA560050 heart .b 61 to 613 2 to 554   capped   553/553
(100 %)
0 diff
(100 %id)
AU124470   .b 61 to 766 2 to 707   capped   706/706
(100 %)
0 diff
(100 %id)
DB251215 uterus .b 61 to 615 2 to 556   capped   555/555
(100 %)
0 diff
(100 %id)
CR606023 neuroblastoma .b 71 to 2033 1 to 1963 exact     1963/1963
(100 %)
0 diff
(100 %id)
AL536282 brain, fetal brain .b 71 to 963 1 to 893       893/893
(100 %)
1 diff
(99.9 %id)
DA729838   .b 72 to 857 2 to 787   capped   786/790
(99 %)
2 diff
(99.8 %id)
DA381932 thalamus .b 74 to 612 2 to 540   capped   539/539
(100 %)
0 diff
(100 %id)
TI_57242546   .b 74 to 691 32 to 661       628/1126
(55 %)
25 diff
(97.8 %id)
AU130548   .b 76 to 715 2 to 641   capped   640/640
(100 %)
2 diff
(99.7 %id)
BP211619 cerebrum .b 87 to 661 1 to 575       575/575
(100 %)
0 diff
(100 %id)
BM146209 leukopheresis .b 88 to 459 1 to 375       375/403
(93 %)
17 diff
(95.8 %id)
AK313066 caudate nucleus .b 89 to 1948 1 to 1860 H73R     1860/1860
(100 %)
1 diff
(100.0 %id)
BM761467 lymph node, stomach .b 89 to 571 1 to 483       483/483
(100 %)
0 diff
(100 %id)
AU077041   .b 89 to 219 1 to 131       131/131
(100 %)
0 diff
(100 %id)
DA301657 hippocampus .b 90 to 632 2 to 544   capped   543/543
(100 %)
0 diff
(100 %id)
DA741028   .b 90 to 626 2 to 538   capped   537/537
(100 %)
0 diff
(100 %id)
DB128537 thymus .b 90 to 632 2 to 544   capped   543/543
(100 %)
0 diff
(100 %id)
DB263522 uterus .b 90 to 666 2 to 578   capped   577/577
(100 %)
0 diff
(100 %id)
CD386729 embryonic trophoblasts, made from WA01 stemcells .b 91 to 1007 24 to 943       920/943
(97 %)
18 diff
(98.1 %id)
TI_57240701   .b 91 to 804 23 to 749       725/1104
(65 %)
20 diff
(98.2 %id)
DA066782 cerebellum .b 92 to 654 2 to 564   capped   563/563
(100 %)
0 diff
(100 %id)
CR601137 neuroblastoma .b 92 to 2028 1 to 1937 exact     1937/1937
(100 %)
0 diff
(100 %id)
BM470705 leiomyosarcoma, uterus .b 93 to 978 1 to 889       889/1047
(84 %)
10 diff
(99.1 %id)
D82348 testis .b 95 to 2049 1 to 1955 exact     1955/2068
(94 %)
2 diff
(100.0 %id)
DB493704 hypothalamus .b 96 to 609 1 to 514       514/514
(100 %)
4 diff
(99.3 %id)
BJ990491 hepatoblastoma .b 99 to 691 9 to 600       592/600
(98 %)
8 diff
(98.7 %id)
DA910957   .b 100 to 668 2 to 570   capped   569/569
(100 %)
0 diff
(100 %id)
BM149272 leukopheresis .b 100 to 589 1 to 489       489/489
(100 %)
9 diff
(98.2 %id)
DB121027 thymus .b 100 to 668 2 to 570   capped   569/569
(100 %)
0 diff
(100 %id)
TI_57146154   .b 103 to 857 67 to 822       756/838
(90 %)
18 diff
(97.9 %id)
TI_45216516   .b 103 to 857 126 to 884       759/1069
(71 %)
15 diff
(98.6 %id)
AL544657 placenta, Placenta Cot 25-normalized .b 104 to 953 1 to 851       851/851
(100 %)
11 diff
(98.8 %id)
BQ225743 melanotic melanoma, skin .b 104 to 804 1 to 706       706/861
(81 %)
11 diff
(98.8 %id)
DA631120 Kidney .b 104 to 674 2 to 572   capped   571/571
(100 %)
0 diff
(100 %id)
DA714528   .b 104 to 669 2 to 567   capped   566/566
(100 %)
0 diff
(100 %id)
DB110665 thymus .b 104 to 668 2 to 566   capped   565/565
(100 %)
0 diff
(100 %id)
DB009584 colon, tumor tissue .b 107 to 675 2 to 570   capped   569/569
(100 %)
0 diff
(100 %id)
DB188396 liver, tumor tissue .b 107 to 673 2 to 568   capped   567/567
(100 %)
0 diff
(100 %id)
DA015791 adrenal gland .b 109 to 659 2 to 552   capped   551/551
(100 %)
0 diff
(100 %id)
DA066295 cerebellum .b 109 to 660 2 to 553   capped   552/552
(100 %)
0 diff
(100 %id)
DA087249 cerebellum .b 109 to 675 2 to 568   capped   567/567
(100 %)
0 diff
(100 %id)
DA463109   .b 109 to 669 2 to 562   capped   561/561
(100 %)
0 diff
(100 %id)
TI_57178589   .b 109 to 687 49 to 633       585/964
(60 %)
20 diff
(98.0 %id)
DA745131   .b 109 to 673 2 to 566   capped   565/565
(100 %)
0 diff
(100 %id)
DB192139 ovary, tumor tissue .b 109 to 662 2 to 555   capped   554/554
(100 %)
0 diff
(100 %id)
DA851254 placenta .b 111 to 682 2 to 573   capped   572/572
(100 %)
0 diff
(100 %id)
DA969551 stomach .b 111 to 615 2 to 506   capped   505/505
(100 %)
0 diff
(100 %id)
BP381813 adipose tissue .b 112 to 725 1 to 614       614/614
(100 %)
0 diff
(100 %id)
D89976 placenta .b 113 to 2049 1 to 1937 exact     1937/1940
(99 %)
1 diff
(100.0 %id)
BQ420448 embryonal carcinoma, cell line, testis .b 113 to 952 1 to 849       849/871
(97 %)
9 diff
(99.0 %id)
TI_57197382   .b 113 to 949 66 to 902       837/902
(92 %)
6 diff
(99.4 %id)
AU133904 ovary, tumor tissue .b 113 to 859 2 to 753   capped   752/796
(94 %)
10 diff
(98.8 %id)
CR609807 B cells (Ramos cell line) .b 114 to 1988 1 to 1875 exact     1875/1875
(100 %)
0 diff
(100 %id)
CX760097 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .b 114 to 846 1 to 733     Submitted on the opposite strand 733/733
(100 %)
0 diff
(100 %id)
TI_57178799   .b 115 to 883 68 to 833       766/834
(91 %)
10 diff
(98.9 %id)
BG491556 amelanotic melanoma, cell line, skin .b 116 to 990 1 to 885       885/948
(93 %)
34 diff
(96.5 %id)
CR594366 fetal liver .b 117 to 2029 1 to 1913 exact     1913/1913
(100 %)
0 diff
(100 %id)
BX423805 fetal liver, Liver .b 117 to 1009 1 to 894       894/894
(100 %)
3 diff
(99.7 %id)
BX427611 fetal liver, Liver .b 117 to 1097 1 to 975       975/1048
(93 %)
12 diff
(98.9 %id)
TI_57216472   .b 117 to 874 29 to 786       758/786
(96 %)
8 diff
(99.0 %id)
DA630525 Kidney .b 117 to 668 2 to 553   capped   552/552
(100 %)
0 diff
(100 %id)
DA822058 pericardium .b 117 to 672 2 to 557   capped   556/556
(100 %)
0 diff
(100 %id)
DB017868 esophageal, tumor tissue .b 117 to 678 2 to 563   capped   562/562
(100 %)
0 diff
(100 %id)
CR617706 placenta .b 118 to 2023 1 to 1906 exact     1906/1906
(100 %)
0 diff
(100 %id)
DA071179 cerebellum .b 119 to 655 2 to 538   capped   537/537
(100 %)
0 diff
(100 %id)
BU541391 carcinoma, cell line, Prostate .b 119 to 978 1 to 870       870/924
(94 %)
21 diff
(97.8 %id)
CN280756 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .b 120 to 838 1 to 719       719/719
(100 %)
0 diff
(100 %id)
BU176990 melanotic melanoma, skin .b 120 to 977 1 to 863       863/863
(100 %)
10 diff
(98.9 %id)
BU902588 leiomyosarcoma, uterus .b 120 to 1004 1 to 885       883/889
(99 %)
3 diff
(99.7 %id)
BM450765 eye, retinoblastoma .b 124 to 856 1 to 738       738/1105
(66 %)
14 diff
(98.8 %id)
BQ056143 lymph, lymphoma, cell line .b 124 to 1084 1 to 962       962/1003
(95 %)
20 diff
(98.1 %id)
BQ059928 lymph, lymphoma, cell line .b 124 to 958 1 to 842       842/983
(85 %)
14 diff
(98.6 %id)
BQ071911 brain, neuroblastoma, cell line .b 124 to 979 1 to 868       868/1056
(82 %)
16 diff
(98.5 %id)
BQ642564 lymph, lymphoma, cell line .b 124 to 1033 1 to 915       915/922
(99 %)
10 diff
(99.0 %id)
AL534454 brain, fetal brain .b 125 to 1068 1 to 942       942/942
(100 %)
5 diff
(99.5 %id)
BE271190 Burkitt lymphoma, lymph .b 125 to 966 32 to 887       813/960
(84 %)
35 diff
(96.4 %id)
BE618439 eye, retinoblastoma .b 127 to 840 1 to 706   AAA Possibly primed on the genome, locally A rich (11/12 A in genome downstream of last aligned base) 707/892
(79 %)
18 diff
(98.0 %id)
BM907355 large cell carcinoma, lung .b 128 to 985 1 to 863       863/990
(87 %)
12 diff
(98.8 %id)
TI_57174494   .b 130 to 777 34 to 687       654/809
(80 %)
18 diff
(97.8 %id)
TI_45208877   .b 132 to 815 92 to 776       685/776
(88 %)
8 diff
(99.0 %id)
TI_45212713   .b 132 to 816 89 to 773       685/773
(88 %)
8 diff
(99.0 %id)
TI_45213274   .b 132 to 859 123 to 849       727/902
(80 %)
16 diff
(98.3 %id)
DA902722   .b 133 to 696 2 to 565   capped   564/564
(100 %)
0 diff
(100 %id)
AB062403   .b 135 to 2056 1 to 1922 exact AAA   1922/1922
(100 %)
0 diff
(100 %id)
TI_45214989   .b 135 to 977 91 to 929       837/998
(83 %)
24 diff
(97.6 %id)
TI_44344802   .b 135 to 983 93 to 942       850/958
(88 %)
28 diff
(97.1 %id)
BM474597 eye, retinoblastoma .b 136 to 982 1 to 852       852/1061
(80 %)
15 diff
(98.6 %id)
TI_57166840   .b 137 to 671 31 to 566       536/566
(94 %)
10 diff
(98.3 %id)
BM802869 duodenal adenocarcinoma, cell line, small intestine .b 138 to 817 1 to 683       683/920
(74 %)
5 diff
(99.5 %id)
BC008879 Pancreas, epithelioid carcinoma .b 140 to 2047 1 to 1908 exact available from MGC, AAA   1908/1908
(100 %)
0 diff
(100 %id)
BM544482 brain, hippocampus .b 140 to 1162 21 to 1037       1017/1045
(97 %)
30 diff
(97.2 %id)
AL536713 brain, fetal brain .b 141 to 1018 1 to 876       876/876
(100 %)
2 diff
(99.8 %id)
DB499131 hypothalamus .b 142 to 612 1 to 471       471/471
(100 %)
1 diff
(99.8 %id)
BC007306 Eye, retinoblastoma .b 142 to 2047 1489 to 3395 exact tiling clone, AAA   1907/3369
(56 %)
6 diff
(99.9 %id)
CR600478 neuroblastoma .b 147 to 2034 1 to 1888 exact     1888/1888
(100 %)
0 diff
(100 %id)
AL518611 brain, neuroblastoma, neuroblastoma cells .b 147 to 1053 1 to 908   fully sequenced,   908/908
(100 %)
5 diff
(99.5 %id)
CR612551 neuroblastoma .b 148 to 2057 1 to 1910 exact     1910/1910
(100 %)
0 diff
(100 %id)
AL513670 neuroblastoma, placenta .b 148 to 1149 1 to 1003   fully sequenced,   1003/1003
(100 %)
3 diff
(99.8 %id)
AU118078 whole embryo, mainly head .b 151 to 942 11 to 803   capped   793/793
(100 %)
5 diff
(99.4 %id)
BM742826 stomach .b 153 to 783 1 to 631       631/631
(100 %)
0 diff
(100 %id)
BM784321 stomach .b 153 to 763 1 to 611       611/611
(100 %)
0 diff
(100 %id)
BM783482 stomach .b 153 to 713 1 to 561       561/561
(100 %)
0 diff
(100 %id)
BM745617 stomach .b 153 to 714 1 to 562       562/562
(100 %)
0 diff
(100 %id)
BM799523 eye, retinoblastoma .b 155 to 1092 1 to 939       939/1086
(86 %)
10 diff
(99.1 %id)
DA482724   .b 156 to 727 2 to 573   capped   572/572
(100 %)
0 diff
(100 %id)
BQ643269 lymph, lymphoma, cell line .b 157 to 978 1 to 835       833/922
(90 %)
17 diff
(98.2 %id)
BQ881201 lymph, lymphoma, cell line .b 157 to 1045 1 to 890       890/891
(99 %)
2 diff
(99.8 %id)
DA730105   .b 158 to 967 2 to 815   capped   814/817
(99 %)
12 diff
(98.6 %id)
DA998661 breast, tumor tissue .b 158 to 730 2 to 574   capped   573/573
(100 %)
0 diff
(100 %id)
DB017377 esophageal, tumor tissue .b 158 to 724 2 to 568   capped   567/567
(100 %)
0 diff
(100 %id)
BU167211 eye, retinoblastoma .b 160 to 986 1 to 831       831/946
(87 %)
23 diff
(97.6 %id)
BI911517 leukocyte .b 167 to 994 7 to 836       830/844
(98 %)
24 diff
(97.2 %id)
TI_57232859   .b 167 to 994 7 to 836       830/844
(98 %)
24 diff
(97.2 %id)
TI_1948240335   .b 169 to 1084 132 to 1044       913/1357
(67 %)
32 diff
(97.7 %id)
TI_1948240336   .b 169 to 1251 125 to 1200       1002/1304
(76 %)
33 diff
(97.5 %id)
TI_1948240597   .b 169 to 1180 123 to 1127       1005/1380
(72 %)
35 diff
(97.5 %id)
TI_1948240598   .b 169 to 1102 126 to 1046       921/1272
(72 %)
27 diff
(97.9 %id)
TI_1948241168   .b 169 to 1092 125 to 1044       920/1363
(67 %)
16 diff
(98.9 %id)
TI_1948241169   .b 169 to 1177 126 to 1139       1014/1339
(75 %)
31 diff
(97.7 %id)
EL733345 mixed .b 170 to 815 1 to 646       646/657
(98 %)
1 diff
(99.9 %id)
BF208020 bladder, carcinoma, cell line .b 173 to 688 1 to 516       516/516
(100 %)
0 diff
(100 %id)
BE791504 lung, small cell carcinoma .b 186 to 985 1 to 795       795/865
(91 %)
15 diff
(98.3 %id)
NM_004044.6   .b 189 to 2066 207 to 2084 exact RefSeq, AAA Possibly primed on the genome, locally A rich (11/12 A in genome downstream of last aligned base) 2084/2084
(100 %)
0 diff
(100 %id)
BQ352917 head_neck .b 204 to 577 422 to 47       376/422
(89 %)
6 diff
(98.6 %id)
BG285066 adenocarcinoma, cell line, Prostate .b 204 to 857 1 to 653       653/1058
(61 %)
3 diff
(99.8 %id)
BG954229 colon .b 212 to 362 12 to 160       149/163
(91 %)
8 diff
(95.1 %id)
BP267339 thyroid .b 213 to 789 1 to 577       577/577
(100 %)
0 diff
(100 %id)
CR987888 T-Lymphocytes .b 281 to 1187 1 to 908       908/908
(100 %)
2 diff
(99.8 %id)
BG762867 melanotic melanoma, high MDR (cell line), skin .b 294 to 1069 1 to 774       774/774
(100 %)
2 diff
(99.8 %id)
TI_154171003   .b 294 to 978 90 to 783       694/878
(79 %)
33 diff
(96.3 %id)
TI_154171071   .b 294 to 857 94 to 668       575/1243
(46 %)
23 diff
(98.2 %id)
BQ069068 brain, neuroblastoma, cell line .b 296 to 1186 1 to 891       891/995
(89 %)
14 diff
(98.6 %id)
ES314405 occipital scalp hair, skin .b 315 to 469 1 to 156       156/156
(100 %)
1 diff
(99.4 %id)
BQ059430 lymph, lymphoma, cell line .b 337 to 1270 1 to 939       939/1020
(92 %)
14 diff
(98.7 %id)
DA538840 Kidney .b 371 to 956 2 to 587   capped   586/586
(100 %)
0 diff
(100 %id)
TI_154172195   .b 377 to 981 80 to 684       605/606
(99 %)
3 diff
(99.6 %id)
BP206922 coronary artery .b 419 to 1002 1 to 584       584/584
(100 %)
0 diff
(100 %id)
CV319592 nervous_tumor .b 426 to 753 330 to 3     Submitted on the opposite strand 328/330
(99 %)
0 diff
(100 %id)
BU158499 embryonal carcinoma, cell line, testis .b 449 to 1379 1 to 936       936/936
(100 %)
23 diff
(97.6 %id)
TI_154177146   .b 487 to 1027 81 to 620       540/541
(99 %)
11 diff
(98.0 %id)
TI_154177710   .b 487 to 1264 69 to 843       775/839
(92 %)
15 diff
(98.3 %id)
BU171885 melanotic melanoma, skin .b 492 to 1379 1 to 895       895/895
(100 %)
10 diff
(98.9 %id)
BU507145 leiomyosarcoma, uterus .b 492 to 1277 1 to 789       789/994
(79 %)
12 diff
(98.8 %id)
TI_154173155   .b 509 to 1072 80 to 645       566/640
(88 %)
22 diff
(96.6 %id)
TI_45215979   .b 589 to 1344 77 to 829       753/830
(90 %)
13 diff
(98.5 %id)
BM454526 embryonal carcinoma, cell line, testis .b 632 to 1499 1 to 869       869/1020
(85 %)
6 diff
(99.5 %id)
BQ068593 brain, neuroblastoma, cell line .b 634 to 1617 23 to 1010       988/1015
(97 %)
31 diff
(97.0 %id)
BF082373 breast_normal .b 674 to 929 254 to 2       253/254
(99 %)
0 diff
(100 %id)
BE928941 placenta_normal .b 676 to 934 269 to 13       257/271
(94 %)
3 diff
(98.9 %id)
BE928974 placenta_normal .b 676 to 934 269 to 13       257/271
(94 %)
3 diff
(98.9 %id)
CX164047 human embryonic stem cells differentiated toan early endodermal cell type .b 685 to 1475 1 to 791       791/791
(100 %)
0 diff
(100 %id)
AW499837 lymph .b 691 to 1207 5 to 521       517/521
(99 %)
5 diff
(99.1 %id)
TI_154153891   .b 694 to 1337 80 to 721       642/643
(99 %)
10 diff
(98.5 %id)
TI_57230373   .b 725 to 1576 89 to 942       854/860
(99 %)
26 diff
(97.0 %id)
CF134699 CNCAP(3)T-225 cell line, Prostate .b 731 to 1345 8 to 622       615/622
(98 %)
6 diff
(99.1 %id)
TI_154162726   .b 731 to 1497 81 to 847       767/1134
(67 %)
15 diff
(98.7 %id)
BI260220 cervical carcinoma cell line, cervix .b 763 to 1668 1 to 911       911/996
(91 %)
22 diff
(97.8 %id)
CX782173 human embryonic stem cells .b 765 to 1541 1 to 777       777/777
(100 %)
0 diff
(100 %id)
FN060902 breast carcinoma .b 772 to 860 1 to 89       89/89
(100 %)
0 diff
(100 %id)
BU956890 adenocarcinoma, cell line, breast .b 776 to 1650 1 to 888       888/888
(100 %)
16 diff
(98.2 %id)
TI_1948241171   .b 778 to 1947 1288 to 128       1052/1362
(77 %)
34 diff
(97.6 %id)
BM716903 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .b 780 to 1312 1 to 533       533/533
(100 %)
1 diff
(99.9 %id)
TI_151776591   .b 780 to 1341 98 to 661       564/1124
(50 %)
21 diff
(98.2 %id)
DA278735 corpus callosum .b 784 to 1336 2 to 554   capped   553/553
(100 %)
0 diff
(100 %id)
BQ316990 colon .b 789 to 1354 566 to 1       566/566
(100 %)
1 diff
(99.9 %id)
TI_57187138   .b 829 to 1583 81 to 835       755/755
(100 %)
0 diff
(100 %id)
BI858168 breast, mammary adenocarcinoma, cell line .b 830 to 1583 1 to 754       754/754
(100 %)
0 diff
(100 %id)
TI_1948240599   .b 831 to 1947 1252 to 128       1123/1336
(84 %)
62 diff
(95.4 %id)
TI_154177418   .b 835 to 1447 80 to 694       615/615
(100 %)
21 diff
(96.6 %id)
TI_154177432   .b 835 to 1446 80 to 692       613/613
(100 %)
34 diff
(94.5 %id)
DA213784 brain .b 863 to 1401 2 to 540   capped   539/539
(100 %)
0 diff
(100 %id)
CN280750 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .b 889 to 1668 1 to 780       780/781
(99 %)
2 diff
(99.8 %id)
AA314232 colon .b 905 to 1234 1 to 330       330/330
(100 %)
0 diff
(100 %id)
TI_154180530   .b 907 to 1668 69 to 831       763/930
(82 %)
12 diff
(98.8 %id)
BI861841 breast, mammary adenocarcinoma, cell line .b 922 to 1581 1 to 660       660/660
(100 %)
0 diff
(100 %id)
TI_57191349   .b 922 to 1581 52 to 711       660/660
(100 %)
0 diff
(100 %id)
BM460107 leiomyosarcoma, uterus .b 926 to 1876 1 to 956       956/1037
(92 %)
29 diff
(97.3 %id)
BE697263 colon .b 927 to 1463 541 to 5       537/544
(98 %)
1 diff
(99.9 %id)
BE697290 colon .b 927 to 1461 544 to 8       537/552
(97 %)
0 diff
(100 %id)
BE697228 colon .b 928 to 1460 535 to 3       533/535
(99 %)
5 diff
(99.1 %id)
BU171700 melanotic melanoma, skin .b 977 to 1829 12 to 865       854/868
(98 %)
6 diff
(99.4 %id)
TI_1948240338   .b 981 to 1947 1090 to 128       963/1298
(74 %)
37 diff
(97.2 %id)
TI_1948240600   .b 981 to 1947 1093 to 129       965/1352
(71 %)
17 diff
(98.8 %id)
TI_1948240337   .b 983 to 1947 1091 to 126       964/1308
(73 %)
41 diff
(96.9 %id)
TI_1948241170   .b 996 to 1947 1064 to 128       937/1263
(74 %)
21 diff
(98.4 %id)
BE813117 amnion_normal .b 1015 to 1192 1 to 178       178/178
(100 %)
8 diff
(95.6 %id)
BX427610 fetal liver, Liver .b 1018 to 2029 1002 to 1       1002/1018
(98 %)
24 diff
(97.7 %id)
AA453922   .b 1022 to 1569 1 to 548       548/549
(99 %)
2 diff
(99.7 %id)
AL518610 brain, neuroblastoma, neuroblastoma cells .b 1023 to 2034 1009 to 1   fully sequenced,   1009/1009
(100 %)
19 diff
(98.2 %id)
TI_154172172   .b 1055 to 1683 89 to 720       632/1199
(52 %)
15 diff
(98.8 %id)
BM796158 Ascites, stomach .b 1066 to 1540 1 to 475       475/475
(100 %)
0 diff
(100 %id)
BE893263 melanotic melanoma, skin .b 1081 to 1825 1 to 743       743/888
(83 %)
9 diff
(99.0 %id)
BX423804 fetal liver, Liver .b 1087 to 1995 909 to 1       909/909
(100 %)
7 diff
(99.3 %id)
AL534453 brain, fetal brain .b 1092 to 2034 937 to 1       937/937
(100 %)
8 diff
(99.2 %id)
BI490842 pooled brain, lung, testis .b 1092 to 1983 904 to 2       903/904
(99 %)
30 diff
(96.7 %id)
TI_43960842   .b 1092 to 1983 904 to 2       903/904
(99 %)
30 diff
(96.7 %id)
BP430784   .b 1099 to 1477 7 to 385       379/385
(98 %)
0 diff
(100 %id)
BY993701   .b 1107 to 1799 29 to 721       693/721
(96 %)
6 diff
(99.2 %id)
BM989997 lung, Lung Focal Fibrosis .b 1111 to 1827 15 to 731     Submitted on the opposite strand 717/717
(100 %)
0 diff
(100 %id)
AL513669 neuroblastoma, placenta .b 1119 to 2057 936 to 1   fully sequenced,   936/936
(100 %)
11 diff
(98.9 %id)
AL566452 brain, fetal brain .b 1121 to 2004 881 to 1       881/885
(99 %)
19 diff
(97.9 %id)
BQ425806 leiomyosarcoma, uterus .b 1126 to 1985 1 to 861       861/863
(99 %)
3 diff
(99.7 %id)
BM740986 stomach .b 1131 to 1696 1 to 566       566/566
(100 %)
0 diff
(100 %id)
BE697293 colon .b 1140 to 1461 330 to 8       323/330
(97 %)
0 diff
(100 %id)
AL570815 placenta, Placenta Cot 25-normalized .b 1140 to 2001 864 to 1       864/864
(100 %)
39 diff
(95.5 %id)
BM817800 stomach .b 1182 to 1821 1 to 640       640/640
(100 %)
0 diff
(100 %id)
EC536319 Prostate .b 1188 to 1295 1 to 107       107/107
(100 %)
3 diff
(97.2 %id)
TI_154131650   .b 1202 to 2047 923 to 89   AAA   835/962
(86 %)
19 diff
(98.1 %id)
BE780899 eye, retinoblastoma .b 1216 to 1983 1 to 764       764/809
(94 %)
23 diff
(97.2 %id)
BG491952 amelanotic melanoma, cell line, skin .b 1246 to 2006 763 to 1       763/764
(99 %)
9 diff
(98.9 %id)
AL536281 brain, fetal brain .b 1252 to 1985 775 to 41       735/792
(92 %)
15 diff
(98.2 %id)
TI_149310445   .b 1253 to 2056 890 to 91   AAA   800/944
(84 %)
15 diff
(98.5 %id)
BG762674 melanotic melanoma, high MDR (cell line), skin .b 1257 to 2049 2 to 799       798/905
(88 %)
14 diff
(98.5 %id)
TI_149307330   .b 1258 to 2047 879 to 91   AAA   789/986
(80 %)
15 diff
(98.5 %id)
TI_149301645   .b 1263 to 2055 868 to 80   AAA   789/940
(83 %)
5 diff
(99.5 %id)
BQ008581 Chondrosarcoma, Left Pubic Bone .b 1288 to 2047 769 to 19   AAA   751/751
(100 %)
11 diff
(98.6 %id)
BG250822 adenocarcinoma, cell line, Liver .b 1290 to 2056 1 to 776       776/905
(85 %)
17 diff
(98.2 %id)
TI_154061612   .b 1298 to 2047 841 to 94   AAA   748/955
(78 %)
8 diff
(99.2 %id)
FN082087 breast carcinoma .b 1300 to 1396 1 to 92       92/103
(89 %)
5 diff
(95.2 %id)
BQ774913 Bone, Human Chondrosarcoma Cell Line .b 1303 to 2047 759 to 19   AAA   741/747
(99 %)
4 diff
(99.5 %id)
BM979136 lung, Primary Lung Epithelial Cells .b 1317 to 2047 748 to 19   AAA   730/730
(100 %)
3 diff
(99.6 %id)
BU685206 lung, Primary Lung Cystic Fibrosis EpithelialCells .b 1329 to 2055 744 to 19   AAA   726/726
(100 %)
1 diff
(99.9 %id)
CB851320 lung .b 1333 to 2056 741 to 19   AAA   723/723
(100 %)
1 diff
(99.9 %id)
BQ319266 colon .b 1335 to 1766 440 to 1       440/441
(99 %)
29 diff
(93.5 %id)
BM826898 Ascites, stomach .b 1340 to 1716 1 to 377       377/377
(100 %)
0 diff
(100 %id)
BU189824 eye, retinoblastoma .b 1352 to 2049 1 to 697       697/735
(94 %)
2 diff
(99.8 %id)
BQ222716 epithelioid carcinoma, Pancreas .b 1367 to 2056 1 to 690       690/698
(98 %)
1 diff
(99.9 %id)
CN280743 embryonic stem cells, DMSO-treated H9 cellline .b 1377 to 1963 1 to 587       587/587
(100 %)
0 diff
(100 %id)
AA228145 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .b 1383 to 1859 1 to 477   fully sequenced,   477/477
(100 %)
0 diff
(100 %id)
BQ009887 Chondrosarcoma, Left Pubic Bone .b 1383 to 2056 690 to 19   AAA   672/672
(100 %)
1 diff
(99.9 %id)
CA444723 lung, Metastatic Chondrosarcoma .b 1383 to 2056 690 to 19   AAA   672/672
(100 %)
1 diff
(99.9 %id)
BU738489 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .b 1384 to 2056 688 to 19   AAA   670/670
(100 %)
3 diff
(99.6 %id)
AW389665 stomach .b 1389 to 1946 559 to 3       557/559
(99 %)
2 diff
(99.7 %id)
BM792992 Ascites, stomach .b 1393 to 1928 1 to 536       536/536
(100 %)
0 diff
(100 %id)
AW578839 colon .b 1397 to 1973 578 to 2       577/583
(98 %)
5 diff
(99.2 %id)
BE963472 eye, retinoblastoma .b 1397 to 2024 646 to 16   AAA Possibly primed on the genome, locally A rich (11/12 A in genome downstream of last aligned base) 631/922
(68 %)
6 diff
(99.4 %id)
TI_159696417   .b 1397 to 2047 699 to 51   AAA   649/920
(70 %)
2 diff
(99.8 %id)
AA353782   .b 1400 to 1603 1 to 204       204/204
(100 %)
0 diff
(100 %id)
CA420707 Bone, Enchondroma cell line .b 1401 to 2047 665 to 19   AAA   647/647
(100 %)
0 diff
(100 %id)
TI_59386098   .b 1407 to 1961 102 to 666       565/930
(60 %)
25 diff
(97.4 %id)
BQ650737 hepatocellular carcinoma, cell line, Liver .b 1409 to 2055 1 to 647   AAA   647/647
(100 %)
0 diff
(100 %id)
CA418137 Bone, Human Chondrosarcoma Cell Line .b 1411 to 2047 655 to 19   AAA   637/637
(100 %)
0 diff
(100 %id)
BE270941 Burkitt lymphoma, lymph .b 1425 to 2015 592 to 1       592/592
(100 %)
3 diff
(99.5 %id)
AW192658 adenocarcinoma, Pancreas .b 1432 to 2057 626 to 1       626/628
(99 %)
1 diff
(99.9 %id)
AW360771 colon .b 1445 to 1968 523 to 2       522/523
(99 %)
3 diff
(99.5 %id)
BM997569 lung, Metastatic Chondrosarcoma .b 1446 to 2056 629 to 19   AAA   611/619
(98 %)
0 diff
(100 %id)
AW360768 colon .b 1449 to 1960 516 to 1       516/517
(99 %)
24 diff
(95.4 %id)
AW360773 colon .b 1449 to 1978 534 to 5       530/534
(99 %)
3 diff
(99.5 %id)
BM560301 astrocytoma grade IV, cell line, brain .b 1461 to 2056 1 to 596   AAA   596/596
(100 %)
0 diff
(100 %id)
EC564038 Prostate .b 1487 to 1569 82 to 1       82/89
(92 %)
1 diff
(98.9 %id)
BJ990492 hepatoblastoma .b 1488 to 1967 480 to 1       480/480
(100 %)
0 diff
(100 %id)
BF350067 head_neck .b 1504 to 1772 272 to 2       271/289
(93 %)
4 diff
(98.7 %id)
FN168640 breast carcinoma .b 1507 to 1595 1 to 89       89/89
(100 %)
0 diff
(100 %id)
CA337789 1st pharyngeal arch (pooled) .b 1514 to 2050 1 to 537       537/537
(100 %)
0 diff
(100 %id)
AU144731 whole embryo, mainly head .b 1521 to 2056 533 to 1       533/576
(92 %)
9 diff
(98.5 %id)
AU155069 ovary, tumor tissue .b 1530 to 2047 517 to 1       517/522
(99 %)
13 diff
(97.6 %id)
DB550943 hippocampus .b 1543 to 2054 1 to 512     Submitted on the opposite strand 512/512
(100 %)
1 diff
(99.9 %id)
DB570237 hypothalamus .b 1543 to 2056 1 to 514     Submitted on the opposite strand 514/514
(100 %)
4 diff
(99.3 %id)
AW882961 ovary .b 1547 to 1972 435 to 10       426/438
(97 %)
1 diff
(99.8 %id)
AA247336   .b 1553 to 1876 1 to 316       316/316
(100 %)
22 diff
(93.1 %id)
AA521289 germinal center B cell .b 1556 to 1943 388 to 1       389/391
(99 %)
48 diff
(87.8 %id)
CB158520 Liver .b 1557 to 2047 1 to 491   AAA   491/491
(100 %)
0 diff
(100 %id)
TI_57228330   .b 1559 to 2056 59 to 556   AAA   498/498
(100 %)
21 diff
(95.8 %id)
FN153226 breast carcinoma .b 1571 to 1663 1 to 93       93/93
(100 %)
3 diff
(96.8 %id)
BF375158 stomach .b 1575 to 1967 396 to 2       395/397
(99 %)
11 diff
(97.3 %id)
AI160152 brain, glioblastoma (pooled) .b 1577 to 2047 471 to 1       471/471
(100 %)
0 diff
(100 %id)
DB549856 hippocampus .b 1578 to 2056 1 to 479     Submitted on the opposite strand 479/479
(100 %)
0 diff
(100 %id)
AW882797 ovary .b 1584 to 1974 396 to 6       391/396
(98 %)
1 diff
(99.8 %id)
BE768822 prostate_tumor .b 1589 to 1759 1 to 175       175/175
(100 %)
12 diff
(93.2 %id)
BE765204 nervous_tumor .b 1591 to 1916 327 to 1       327/336
(97 %)
5 diff
(98.6 %id)
BE835089 prostate_normal .b 1591 to 1909 322 to 4       319/330
(96 %)
4 diff
(98.8 %id)
BF370008 prostate_normal .b 1591 to 1895 308 to 2       307/315
(97 %)
3 diff
(99.1 %id)
AU152466   .b 1591 to 2056 466 to 1       466/466
(100 %)
1 diff
(99.8 %id)
AA453416   .b 1592 to 2063 474 to 4       471/474
(99 %)
1 diff
(99.8 %id)
BG942403 blood .b 1596 to 2055 501 to 42   AAA   460/460
(100 %)
14 diff
(97.0 %id)
DB564761 hypothalamus .b 1596 to 2056 1 to 460     Submitted on the opposite strand 460/460
(100 %)
1 diff
(99.8 %id)
FN128601 breast carcinoma .b 1597 to 1673 81 to 5     Submitted on the opposite strand 77/82
(93 %)
0 diff
(100 %id)
BE768841 prostate_tumor .b 1600 to 1876 278 to 1       278/278
(100 %)
7 diff
(97.5 %id)
BE768845 prostate_tumor .b 1600 to 1916 317 to 1       317/317
(100 %)
0 diff
(100 %id)
BE768847 prostate_tumor .b 1600 to 1929 342 to 11       332/342
(97 %)
1 diff
(99.8 %id)
AI339696 adenocarcinoma, colon .b 1601 to 2056 456 to 1       456/456
(100 %)
0 diff
(100 %id)
AW379080 head_neck .b 1608 to 1924 317 to 1       317/341
(92 %)
6 diff
(98.3 %id)
BF349984 head_neck .b 1608 to 1885 279 to 1       279/303
(92 %)
4 diff
(98.7 %id)
DB538813 hippocampus .b 1614 to 2056 1 to 441     Submitted on the opposite strand 441/441
(100 %)
7 diff
(98.5 %id)
BM150488 leukopheresis .b 1619 to 2055 453 to 17   AAA   437/437
(100 %)
12 diff
(97.3 %id)
AW150695 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .b 1649 to 2024 376 to 1       376/376
(100 %)
0 diff
(100 %id)
AU148323   .b 1665 to 2056 392 to 1       392/393
(99 %)
0 diff
(100 %id)
BM694023 eye, Retina Foveal and Macular .b 1668 to 1859 1 to 192   fully sequenced,   192/192
(100 %)
0 diff
(100 %id)
AI093346 uterus .b 1669 to 2047 392 to 14   AAA   379/379
(100 %)
0 diff
(100 %id)
BM150058 leukopheresis .b 1671 to 2056 402 to 17   AAA   386/386
(100 %)
2 diff
(99.5 %id)
BG942478 blood .b 1672 to 2053 426 to 44       383/426
(89 %)
3 diff
(99.3 %id)
BE242989 leukopheresis .b 1733 to 2053 323 to 3       321/323
(99 %)
0 diff
(100 %id)
AI264236 Kidney .b 1734 to 2056 323 to 1       323/323
(100 %)
0 diff
(100 %id)
BE827401 lung_tumor .b 1738 to 1985 254 to 1       254/254
(100 %)
8 diff
(96.9 %id)
CR604622 neuroblastoma .b 1741 to 2049 1 to 309       309/309
(100 %)
0 diff
(100 %id)
BE206500 cervical carcinoma cell line, cervix .b 1745 to 2056 1 to 312   AAA   312/312
(100 %)
0 diff
(100 %id)
BM193610 leukopheresis .b 1756 to 2056 317 to 17   AAA   301/301
(100 %)
1 diff
(99.7 %id)
EC543351 Prostate .b 1767 to 1866 1 to 98       98/98
(100 %)
4 diff
(96.0 %id)
AA228036 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .b 1798 to 1925 128 to 1   fully sequenced,   128/128
(100 %)
1 diff
(99.3 %id)
BM665768 eye, Retina Foveal and Macular .b 1798 to 2056 277 to 19   fully sequenced, AAA   259/259
(100 %)
0 diff
(100 %id)
CK821445 Pancreas, Purified pancreatic islet .b 1802 to 2056 265 to 11   AAA Submitted on the opposite strand 255/259
(98 %)
5 diff
(98.1 %id)
BM353767 Pancreas, Purified pancreatic islet .b 1816 to 2056 1 to 241   AAA   241/241
(100 %)
0 diff
(100 %id)
CN280741 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .b 1826 to 2047 1 to 222   AAA   222/222
(100 %)
0 diff
(100 %id)
FN118191 breast carcinoma .b 1827 to 1918 92 to 1     Submitted on the opposite strand 92/97
(94 %)
1 diff
(99.0 %id)
CK821444 Pancreas, Purified pancreatic islet .b 1843 to 2056 1 to 214   AAA Submitted on the opposite strand 214/214
(100 %)
0 diff
(100 %id)
BE242995 leukopheresis .b 1856 to 2053 200 to 3       198/200
(99 %)
0 diff
(100 %id)
BM353496 Pancreas, Purified pancreatic islet .b 1872 to 2056 185 to 1       185/185
(100 %)
0 diff
(100 %id)
BG033112 breast, mammary adenocarcinoma, cell line .b 1882 to 2056 1 to 175   AAA   175/175
(100 %)
1 diff
(99.5 %id)
FN097811 breast carcinoma .b 1919 to 2039 1 to 117       117/117
(100 %)
3 diff
(97.5 %id)
BE243695 leukopheresis .b 1955 to 2060 107 to 2       106/107
(99 %)
0 diff
(100 %id)
EC500462 Prostate .b 1958 to 2054 101 to 3       99/123
(80 %)
0 diff
(100 %id)
Z20701   .b 1998 to 2055 1 to 60       60/60
(100 %)
2 diff
(96.7 %id)
BE250563 muscle, rhabdomyosarcoma .c 1 to 600 20 to 615       596/615
(96 %)
6 diff
(99.1 %id)
AL518112 brain, neuroblastoma, neuroblastoma cells .c 4 to 1023 1 to 1018   tiling clone,   1018/1018
(100 %)
8 diff
(99.3 %id)
BM479716 eye, retinoblastoma .c 7 to 789 13 to 797   tiling clone,   785/1048
(74 %)
11 diff
(99.0 %id)
BU539695 adenocarcinoma, cell line, breast .c 17 to 559 1 to 547       547/992
(55 %)
20 diff
(98.0 %id)
BF027529 melanotic melanoma, skin .c 23 to 864 25 to 860       838/876
(95 %)
24 diff
(97.3 %id)
BI490016 pooled brain, lung, testis .c 25 to 699 1 to 670       670/670
(100 %)
8 diff
(98.9 %id)
TI_43960840   .c 26 to 699 95 to 763       669/763
(87 %)
8 diff
(99.0 %id)
BG396930 melanotic melanoma, skin .c 30 to 716 2 to 708       707/925
(76 %)
18 diff
(98.1 %id)
BE276787 melanotic melanoma, skin .c 49 to 650 1 to 602       602/603
(99 %)
1 diff
(99.9 %id)
BE384273 melanotic melanoma, skin .c 51 to 681 1 to 630       630/630
(100 %)
7 diff
(98.9 %id)
BP315807 mammary gland .c 105 to 686 1 to 582       582/582
(100 %)
1 diff
(99.9 %id)
DA354838 substantia nigra .c 106 to 668 2 to 564   capped   563/563
(100 %)
2 diff
(99.7 %id)
AK290067 substantia nigra .c 167 to 2222 1 to 2056 T115S tiling clone,   2056/2056
(100 %)
1 diff
(100.0 %id)
DA345773 substantia nigra .c 168 to 743 2 to 578   capped   577/577
(100 %)
2 diff
(99.7 %id)
DA272838 caudate nucleus .c 170 to 716 2 to 549   capped   548/548
(100 %)
2 diff
(99.7 %id)
EL948776 eyeball .c 172 to 753 1 to 582       582/582
(100 %)
9 diff
(98.5 %id)
DA259123 caudate nucleus .c 191 to 760 2 to 571   capped   570/570
(100 %)
0 diff
(100 %id)
BY796139 eye .c 233 to 815 1 to 583       583/583
(100 %)
0 diff
(100 %id)
DA237358 brain .c 303 to 647 2 to 346   capped   345/345
(100 %)
0 diff
(100 %id)
U37436 hepatoma .c 339 to 2114 1 to 1776 D164G     1776/1776
(100 %)
5 diff
(99.8 %id)
AL518111 brain, neuroblastoma, neuroblastoma cells .c 1258 to 2194 933 to 1       871/933
(93 %)
34 diff
(96.4 %id)
BE250385 muscle, rhabdomyosarcoma .c 1428 to 2185 786 to 25       762/791
(96 %)
9 diff
(98.9 %id)
BI820968 pooled brain, lung, testis .d 1 to 751 1 to 751   tiling clone,   751/751
(100 %)
0 diff
(100 %id)
TI_57198439   .d 1 to 751 38 to 788       751/788
(95 %)
6 diff
(99.3 %id)
W02915 melanocyte .d 747 to 992 1 to 247   tiling clone,   247/248
(99 %)
4 diff
(98.4 %id)
N74526 melanocyte .d 2261 to 2545 286 to 1   tiling clone,   286/286
(100 %)
4 diff
(98.7 %id)
AU131213   .e 1 to 740 2 to 741   tiling clone, to resequence, capped   740/740
(100 %)
0 diff
(100 %id)
CR976765 T-Lymphocytes .e 7 to 570 1 to 564       564/564
(100 %)
0 diff
(100 %id)
BM151692 leukopheresis .e 16 to 531 1 to 516       516/516
(100 %)
4 diff
(99.3 %id)
DA064872 cerebellum .e 39 to 528 2 to 491   capped   490/491
(99 %)
2 diff
(99.6 %id)
DB482082 hippocampus .e 39 to 508 1 to 470       470/470
(100 %)
1 diff
(99.8 %id)
BP255169 Kidney .e 39 to 602 1 to 564       564/564
(100 %)
0 diff
(100 %id)
DA270312 caudate nucleus .e 40 to 599 2 to 563   capped   562/562
(100 %)
3 diff
(99.5 %id)
DB481043 hippocampus .e 45 to 517 1 to 473       473/473
(100 %)
0 diff
(100 %id)
BG395250 eye, retinoblastoma .e 48 to 745 1 to 691   tiling clone,   691/693
(99 %)
15 diff
(97.9 %id)
DA386239 thalamus .e 49 to 621 2 to 574   capped   573/573
(100 %)
1 diff
(99.9 %id)
DB188423 liver, tumor tissue .e 49 to 628 2 to 583   capped   582/582
(100 %)
3 diff
(99.5 %id)
BM925836 brain .e 57 to 614 1 to 561       561/1018
(55 %)
10 diff
(99.1 %id)
AU152995   .e 1319 to 1798 485 to 1   tiling clone, to resequence,   485/485
(100 %)
9 diff
(98.2 %id)
BI760350 pooled colon, kidney, stomach .f 1 to 741 1 to 740 I9Y I10F S11Q E13S V14I ... tiling clone,   740/742
(99 %)
18 diff
(97.6 %id)
TI_57148121   .f 5 to 741 33 to 768       736/770
(95 %)
19 diff
(97.6 %id)
BG705531 brain, hypothalamus .g 1 to 649 5 to 653   tiling clone,   653/653
(100 %)
5 diff
(99.3 %id)
BQ054369 blood, natural killer cells, cell line .g 56 to 962 1 to 902 T150S tiling clone,   902/1013
(89 %)
10 diff
(99.1 %id)
BQ310671 breast_normal .g 937 to 1574 11 to 649   tiling clone,   639/649
(98 %)
10 diff
(98.5 %id)
AW835346 leiomios .g 1244 to 1609 209 to 574   tiling clone,   366/574
(63 %)
8 diff
(98.7 %id)
BQ940440 brain, neuroblastoma, cell line .h 1 to 704 1 to 707 E60D M151N N152E H154T Q155F ... tiling clone,   707/913
(77 %)
5 diff
(99.5 %id)
BE245330 leukopheresis .i 1 to 573 574 to 2 L2H L7X F21L L31X tiling clone,   573/574
(99 %)
2 diff
(99.7 %id)
DW422643 Liver .i 105 to 383 16 to 294       279/294
(94 %)
7 diff
(97.7 %id)
AI075185 liver and spleen .j -9 to 702 740 to 29 D2G Y5T P7Q D8I T14I ... tiling clone, AAA   712/714
(99 %)
16 diff
(97.8 %id)
BG260150 bladder, transitional cell papilloma, cell line .j 118 to 672 1 to 557   tiling clone,   557/559
(99 %)
3 diff
(99.5 %id)
EC555837 Prostate .j 334 to 433 1 to 98       98/98
(100 %)
2 diff
(98.0 %id)
BF797295 lymph, lymphoma, cell line .j 438 to 1189 1 to 745       745/929
(80 %)
25 diff
(97.4 %id)
BG032592 breast, mammary adenocarcinoma, cell line .j 443 to 1186 1 to 736   tiling clone,   736/793
(92 %)
13 diff
(98.4 %id)
BM795951 Ascites, stomach .j 457 to 785 1 to 330       330/330
(100 %)
2 diff
(99.4 %id)
AA491074 germinal center B cell .j 559 to 827 1 to 269       269/269
(100 %)
2 diff
(99.3 %id)
BG111331 Bone, osteosarcoma, cell line .j 578 to 1375 1 to 787   tiling clone,   787/920
(85 %)
30 diff
(96.8 %id)
FN089564 breast carcinoma .j 685 to 782 99 to 1     Submitted on the opposite strand 99/99
(100 %)
8 diff
(92.0 %id)
AV746033 Pituitary .j 722 to 1223 1 to 487       487/487
(100 %)
13 diff
(97.4 %id)
AV745365 Pituitary .j 765 to 1339 1 to 564       564/570
(98 %)
15 diff
(97.4 %id)
H59528 liver and spleen .j 976 to 1353 1 to 386       386/387
(99 %)
16 diff
(95.9 %id)
T72712 liver and spleen .j 1015 to 1398 1 to 392       392/395
(99 %)
15 diff
(96.3 %id)
AA203706 liver and spleen .j 1015 to 1747 1 to 724   tiling clone,   724/996
(72 %)
19 diff
(98.1 %id)
BF968002 adrenal cortex carcinoma, cell line, adrenal gland .j 1027 to 1780 1 to 753       753/753
(100 %)
23 diff
(97.0 %id)
BU660479 blood .j 1200 to 1673 11 to 484       474/484
(97 %)
6 diff
(98.8 %id)
BU660924 blood .j 1207 to 1646 1 to 440       440/440
(100 %)
3 diff
(99.4 %id)
H99431 melanocyte .j 1268 to 1664 1 to 398   fully sequenced,   398/398
(100 %)
7 diff
(98.3 %id)
BQ028442 mixed .j 1360 to 2006 665 to 19   AAA   647/647
(100 %)
1 diff
(99.9 %id)
AA219387 brain, neuroepithelial cells .j 1368 to 2006 630 to 1       630/634
(99 %)
20 diff
(96.9 %id)
AA219355 brain, neuroepithelial cells .j 1374 to 2006 627 to 1       627/632
(99 %)
10 diff
(98.5 %id)
AA781387   .j 1495 to 2009 515 to 1   tiling clone,   515/515
(100 %)
0 diff
(100 %id)
AA777379 liver and spleen .j 1509 to 1956 448 to 1       448/448
(100 %)
1 diff
(99.8 %id)
H60400 liver and spleen .j 1563 to 1953 416 to 7       410/468
(87 %)
0 diff
(100 %id)
AA344115 gall bladder .j 1565 to 1854 1 to 291       291/291
(100 %)
1 diff
(99.7 %id)
AW952954   .j 1566 to 1941 1 to 376       376/390
(96 %)
38 diff
(90.3 %id)
H99432 melanocyte .j 1642 to 2006 387 to 21   fully sequenced, AAA   367/367
(100 %)
5 diff
(98.7 %id)
BE144253 head_neck .j 1649 to 2148 576 to 78   tiling clone, Submitted on the opposite strand 499/576
(86 %)
0 diff
(100 %id)
T72644 liver and spleen .j 1710 to 2001 304 to 8       297/309
(96 %)
0 diff
(100 %id)
BQ027246 mixed .j 1724 to 2006 301 to 19   AAA   283/283
(100 %)
1 diff
(99.7 %id)
AI473838 follicular lymphoma, lymph node .j 2042 to 2419 378 to 1   tiling clone,   378/378
(100 %)
0 diff
(100 %id)
AI126262 placenta .k 1 to 433 434 to 2 exact tiling clone,   433/434
(99 %)
0 diff
(100 %id)
AA926862 squamous cell carcinoma from base of tongue, tongue .l 1 to 436 1 to 435   tiling clone, Submitted on the opposite strand 435/435
(100 %)
1 diff
(99.8 %id)
AA564564 adrenal adenoma, adrenal gland .l 331 to 832 516 to 15 exact tiling clone, AAA   502/549
(91 %)
1 diff
(99.9 %id)
BE765197 nervous_tumor .l 378 to 705 1 to 328       328/329
(99 %)
13 diff
(96.1 %id)
AI126827 heart .m 1 to 486 486 to 1 exact tiling clone,   486/486
(100 %)
0 diff
(100 %id)
AA527989 colon .m 11 to 486 476 to 1 W2D D33H P56S G58A L81F ...     476/480
(99 %)
20 diff
(95.9 %id)
AW972145   .m 12 to 483 472 to 1 exact   Submitted on the opposite strand 472/629
(75 %)
0 diff
(100 %id)
TI_149278867   .m 12 to 484 555 to 83 exact AAA   473/1132
(41 %)
3 diff
(99.8 %id)
AA301226 testis .m 26 to 208 1 to 183       183/183
(100 %)
0 diff
(100 %id)
BM969389 lung, Primary Lung Epithelial Cells .m 48 to 484 455 to 19 exact AAA   437/437
(100 %)
2 diff
(99.6 %id)
AI283346 ovary, tumor, 5 pooled (see description) .m 83 to 486 404 to 1 exact     404/404
(100 %)
0 diff
(100 %id)
DA043224 bladder .n 189 to 551 208 to 570 exact tiling clone, capped   569/569
(100 %)
3 diff
(99.5 %id)
BX953242   .o-u 1 to 733 1 to 732 exact tiling clone,   732/732
(100 %)
1 diff
(99.9 %id)
AW954274   .p-u 1 to 719 1 to 722 exact tiling clone,   722/722
(100 %)
18 diff
(97.6 %id)
BY996962   .q-u 1 to 669 10 to 678 exact tiling clone,   669/681
(98 %)
7 diff
(99.0 %id)
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i, .j, .k, .l, .m, .n, .o-u, .p-u, .q-u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes DCI